Journal of the Royal Society of Medicine, Vol 86, Issue 3 137-138, Copyright © 1993 by Royal Society of Medicine
ORIGINAL ARTICLES |
D Michaloudis, N O'Keeffe, K O'Sullivan and TE Healy
Department of Anaesthesia, Withington Hospital, Manchester.
Drugs with anti-emetic properties can exert their actions at more than one receptor site, histamine H1, muscarinic cholinergic or dopaminergic D2 receptors. This study was designed to test the hypothesis that a combination of drugs acting at different receptor sites in lower than standard doses would be at least as effective as a standard therapeutic dose of a single anti-emetic agent. A combination of droperidol, hyoscine and metoclopramide in subtherapeutic doses has been shown to be at least as effective as droperidol (1.25 mg) alone. In both groups there was a low incidence of emetic sequelae in the first 3 hours postoperatively.
This article has been cited by other articles:
![]() |
P. Kranke, A. M. Morin, N. Roewer, H. Wulf, and L. H. Eberhart The Efficacy and Safety of Transdermal Scopolamine for the Prevention of Postoperative Nausea and Vomiting: A Quantitative Systematic Review Anesth. Analg., July 1, 2002; 95(1): 133 - 143. [Abstract] [Full Text] [PDF] |
||||